By
AmyT on
November 3, 2009
Welcome to another “Where Are They Now?” update on a DiabetesMine Design Challenge entrant. This year, we received a paper entry on PicoSulin, a “revolutionary miniature insulin pump with direct Penfill Cartridge loading.”
I heard from the Geneva, Switzerland-based company last week that their website is now live, presenting in particular a new patch pump model (OmniPod competitor) they’re working on called the PicoPatch.
What’s unique about both products is their tiny size and…
Read more »
By
AmyT on
October 12, 2009
MannKind Corp., the most aggressive company pushing ahead on bringing inhalable insulin to market post the Exubera debacle, took a hit last week when it was forced to announce that a critical marketing partnership didn’t pan out. Investors are now fighting over the company’s future.
As a PWD who watched the whole sordid Exubera story play out with a sad smirk on my face (we all knew the product was too clunky and hard to…
Read more »
By
AmyT on
September 30, 2009
Apropos to last week’s post on Testing Driving Insulin, I was thinking about the ‘older’ versions — and discovered a reader letter I received back in February of 2006. It seems just as timely today, considering that research supported the case for continuing to offer patients the option of animal insulin:
“In our systematic review we could not identify substantial differences in the safety and efficacy between insulin species. Many important patient-oriented outcomes like health-related…
Read more »
By
AmyT on
September 22, 2009
How many insulins have you tried? If you’re like most people, you only switch to something new when a better generation comes out, such as when Regular upgraded to Humalog or when NPH upgraded to Lantus. But when it comes to comparing insulin in the same family, say Humalog versus Novolog or Lantus versus Levemir, most of us only try something new when something goes very wrong, such as burning at the injection site. Yech……
Read more »
By
AmyT on
August 31, 2009
New briefs this week: An Australian company that makes “cosmeceuticals” is developing an insulin gel patch in collaboration with the Joslin Diabetes Center at Harvard Medical School. A Japanese company that makes synthetic fabrics is developing an insulin nasal spray with Hoshi University in Tokyo.
Hey, I don’t make this stuff up. As you well know, these kinds of headlines are either tantalizingly exciting, or disgustingly frustrating, depending on how long you’ve had the ‘betes…
Read more »
